Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00053-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Mark A Marzinke und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Transgender Persons, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health, ViiV Healthcare.
Abstract (Originalsprache)
HPTN 083 demonstrated that injectable cabotegravir (CAB) was superior to oral tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) for HIV prevention in cisgender men and transgender women who have sex with men. We previously analyzed 58 infections in the blinded phase of HPTN 083 (16 in the CAB arm and 42 in the TDF-FTC arm).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
- Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
- Department of Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA.
- Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Mark A Marzinke, Jessica M Fogel, Estelle Piwowar-Manning, Elias K Halvas, John Mellors, Peter L Anderson, Deborah Persaud, Craig W Hendrix, Kenneth Mayer, Myron S Cohen, Beatriz Grinsztejn, Raphael J Landovitz, Susan H Eshleman
Förderung
- NIAID NIH HHS
- HHS | National Institutes of Health
- ViiV Healthcare
- Gilead Sciences
Zitieren
APA
Marzinke, M. A., Fogel, J. M., Wang, Z., Piwowar-Manning, E., Kofron, R., Moser, A., Bhandari, P., Gollings, R., Bushman, L. R., Weng, L., Halvas, E. K., Mellors, J., Anderson, P. L., Persaud, D., Hendrix, C. W., McCauley, M., Rinehart, A. R., St Clair, M., Ford, S. L., …, & Eshleman, S. H. (2023). Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00053-23
Vancouver
Marzinke MA, Fogel JM, Wang Z, Piwowar-Manning E, Kofron R, Moser A, et al. Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00053-23
BibTeX
@article{Marzinke2023,
author = {Marzinke, Mark A and Fogel, Jessica M and Wang, Zhe and Piwowar-Manning, Estelle and Kofron, Ryan and Moser, Amber and Bhandari, Pradip and Gollings, Ryann and Bushman, Lane R and Weng, Lei and Halvas, Elias K and Mellors, John and Anderson, Peter L and Persaud, Deborah and Hendrix, Craig W and McCauley, Marybeth and Rinehart, Alex R and St Clair, Marty and Ford, Susan L and Rooney, James F and Adeyeye, Adeola and Chariyalertsak, Suwat and Mayer, Kenneth and Arduino, Roberto C and Cohen, Myron S and Grinsztejn, Beatriz and Hanscom, Brett and Landovitz, Raphael J and Eshleman, Susan H},
title = {Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00053-23}
}
EUVIMED